328 related articles for article (PubMed ID: 27020855)
21. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation.
Zhang H; Ding J; Fan Q; Liu S
Exp Biol Med (Maywood); 2009 Sep; 234(9):1029-36. PubMed ID: 19546355
[TBL] [Abstract][Full Text] [Related]
22. Gq signaling causes glomerular injury by activating TRPC6.
Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
[TBL] [Abstract][Full Text] [Related]
23. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
24. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
25. Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes.
Chen S; He FF; Wang H; Fang Z; Shao N; Tian XJ; Liu JS; Zhu ZH; Wang YM; Wang S; Huang K; Zhang C
Cell Calcium; 2011 Dec; 50(6):523-9. PubMed ID: 21959089
[TBL] [Abstract][Full Text] [Related]
26. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
[TBL] [Abstract][Full Text] [Related]
28. Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.
Yao X; Guo H; Sun M; Meng S; Zhu B; Fang J; Huang J; Wang H; Xing L
J Diabetes Res; 2022; 2022():1329380. PubMed ID: 35480629
[TBL] [Abstract][Full Text] [Related]
29. Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6/p-CaMK4 signaling.
Chen L; Tang YL; Liu ZH; Pan Y; Jiao RQ; Kong LD
Eur J Pharmacol; 2021 Dec; 913():174616. PubMed ID: 34780752
[TBL] [Abstract][Full Text] [Related]
30. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
[TBL] [Abstract][Full Text] [Related]
31. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes.
Kim EY; Alvarez-Baron CP; Dryer SE
Mol Pharmacol; 2009 Mar; 75(3):466-77. PubMed ID: 19052171
[TBL] [Abstract][Full Text] [Related]
32. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
Roshanravan H; Dryer SE
Am J Physiol Renal Physiol; 2014 May; 306(9):F1088-97. PubMed ID: 24553432
[TBL] [Abstract][Full Text] [Related]
33. Tetrandrine Attenuates Podocyte Injury by Inhibiting TRPC6-Mediated RhoA/ROCK1 Pathway.
Mao L; Ding Y; Yu D; Yin J; Yu J
Anal Cell Pathol (Amst); 2022; 2022():7534181. PubMed ID: 36247873
[TBL] [Abstract][Full Text] [Related]
34. TRPC6 and FSGS: the latest TRP channelopathy.
Mukerji N; Damodaran TV; Winn MP
Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
[TBL] [Abstract][Full Text] [Related]
35. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury.
Wang Z; Wei X; Zhang Y; Ma X; Li B; Zhang S; Du P; Zhang X; Yi F
Cell Physiol Biochem; 2009; 24(5-6):619-26. PubMed ID: 19910702
[TBL] [Abstract][Full Text] [Related]
36. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
37. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
38. Mammalian target of rapamycin complex 2 signaling pathway regulates transient receptor potential cation channel 6 in podocytes.
Ding F; Zhang X; Li X; Zhang Y; Li B; Ding J
PLoS One; 2014; 9(11):e112972. PubMed ID: 25393730
[TBL] [Abstract][Full Text] [Related]
39. The calcium-sensing receptor stabilizes podocyte function in proteinuric humans and mice.
Mühlig AK; Steingröver J; Heidelbach HS; Wingerath M; Sachs W; Hermans-Borgmeyer I; Meyer-Schwesinger C; Choi HY; Lim BJ; Patry C; Hoffmann GF; Endlich N; Bracke K; Weiß M; Guse AH; Lassé M; Rinschen MM; Braun F; Huber TB; Puelles VG; Schmitt CP; Oh J
Kidney Int; 2022 Jun; 101(6):1186-1199. PubMed ID: 35271934
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.
Liao R; Liu Q; Zheng Z; Fan J; Peng W; Kong Q; He H; Yang S; Chen W; Tang X; Yu X
PLoS One; 2015; 10(7):e0132724. PubMed ID: 26161538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
